Fresenius SE & Co. KGaA (FRE.DE)
- Previous Close
41.77 - Open
41.85 - Bid --
- Ask 42.59 x --
- Day's Range
41.56 - 42.65 - 52 Week Range
27.26 - 44.06 - Volume
1,059,550 - Avg. Volume
1,207,126 - Market Cap (intraday)
23.949B - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
22.74 - EPS (TTM)
1.87 - Earnings Date Aug 6, 2025
- Forward Dividend & Yield 1.00 (2.36%)
- Ex-Dividend Date May 26, 2025
- 1y Target Est
47.91
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
www.fresenius.com175,202
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FRE.DE
View More
Performance Overview: FRE.DE
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FRE.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FRE.DE
View MoreValuation Measures
Market Cap
23.83B
Enterprise Value
34.93B
Trailing P/E
22.63
Forward P/E
12.39
PEG Ratio (5yr expected)
0.31
Price/Sales (ttm)
1.08
Price/Book (mrq)
1.23
Enterprise Value/Revenue
1.58
Enterprise Value/EBITDA
10.85
Financial Highlights
Profitability and Income Statement
Profit Margin
1.91%
Return on Assets (ttm)
2.68%
Return on Equity (ttm)
5.06%
Revenue (ttm)
22.13B
Net Income Avi to Common (ttm)
1.2B
Diluted EPS (ttm)
1.87
Balance Sheet and Cash Flow
Total Cash (mrq)
2.39B
Total Debt/Equity (mrq)
67.91%
Levered Free Cash Flow (ttm)
1.48B